Retatrutide
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
- Purity:
- ≥99% HPLC
- Sizes available:
- 10 mg
18 compounds we source and verify. Nothing is priced on this page — each one is quoted through a technical consultation matched to your specification, quantity and destination.
18 compounds
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
BPC-157 and TB-500 in a single vial — the pairing most studied together in tissue-repair research.
Growth hormone-releasing hormone analogue used in endocrine signalling research.
Copper-binding tripeptide studied in extracellular matrix and dermal research models.
Essential redox cofactor central to cellular metabolism and sirtuin research.
Modified GRF(1-29) tetrasubstituted analogue without drug affinity complex.
Selective ghrelin receptor (GHS-R1a) agonist pentapeptide.
Stabilised GHRH(1-44) analogue studied in adipose tissue distribution research.
Melanocortin receptor agonist studied in central nervous system signalling.
Bacteriostatic water with lidocaine, 6 mL, for laboratory reconstitution.
No compounds match this filter.
No prices are published. Every compound is quoted through a technical consultation.
| Compound | Also known as | Classification | Research area | Purity | Vial sizes |
|---|---|---|---|---|---|
| Retatrutide | LY3437943, Reta, triple agonist GLP-1/GIP/glucagon | Triple GLP-1 / GIP / glucagon receptor agonist | Metabolic research | ≥99% HPLC | 10 mg |
| Sermorelin | GRF (1-29), GHRH (1-29), Geref | GHRH (1-29) analogue | Growth hormone axis | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| GHK-Cu (Copper Peptide) | GHK-Cu, copper peptide, copper tripeptide-1, Gly-His-Lys copper | Gly-His-Lys tripeptide copper(II) complex | Tissue & repair | ≥99% HPLC | 50 mg Normal, 50 mg Plus |
| NAD+ (Nicotinamide Adenine Dinucleotide) | NAD+, NAD plus, nicotinamide adenine dinucleotide | Nicotinamide adenine dinucleotide | Longevity & cellular | ≥99% HPLC | 250 mg Raw Powder, 300 mg |
| BPC-157 + TB-500 | Body Protection Compound 157, BPC157, Pentadecapeptide BPC 157, PL 14736, TB500, thymosin beta-4, thymosin beta 4 fragment, TB4 | Pentadecapeptide BPC (1-15) + thymosin β4 active fragment (17-23) | Tissue & repair | ≥99% HPLC | 5 mg + 5 mg |
| MOTS-c | MOTSc, mitochondrial ORF of the 12S rRNA type-c | Mitochondrial-derived peptide, 16 aa | Metabolic research | ≥99% HPLC | 10 mg, 20 mg |
| CJC-1295 (sin DAC) | Modified GRF 1-29, Mod GRF (1-29) | Modified GRF (1-29), no DAC | Growth hormone axis | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Ipamorelin | NNC 26-0161 | Pentapeptide GHS-R1a agonist | Growth hormone axis | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Tesamorelin | TH9507, Egrifta | Trans-3-hexenoyl GHRH (1-44) analogue | Growth hormone axis | ≥99% HPLC | 10 mg, 20 mg |
| PT-141 (Bremelanotide) | PT141, bremelanotide | Melanocortin receptor agonist, cyclic heptapeptide | Neurological research | ≥99% HPLC | 5 mg, 10 mg |
| Epitalon | Epithalon, Epithalamin, AEDG peptide, Ala-Glu-Asp-Gly | Ala-Glu-Asp-Gly tetrapeptide | Longevity & cellular | ≥99% HPLC | 20 mg |
| KPV | Lys-Pro-Val, alpha-MSH (11-13) fragment | Lys-Pro-Val tripeptide, α-MSH (11-13) | Tissue & repair | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Semax | Met-Glu-His-Phe-Pro-Gly-Pro, ACTH (4-10) analogue | ACTH (4-10) analogue, heptapeptide | Neurological research | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Selank | TP-7, tuftsin analogue | Tuftsin analogue, heptapeptide | Neurological research | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Pinealon | Glu-Asp-Arg, EDR peptide | Glu-Asp-Arg tripeptide | Longevity & cellular | ≥99% HPLC | 10 mg, 20 mg |
| BAC Water+ (6mL con Lidocaína) | bacteriostatic water with lidocaine, BAC water plus | 0.9% benzyl alcohol + lidocaine, 6 mL | Laboratory supplies | USP grade | 6 mL |
| Vesugen | Lys-Glu-Asp, KED peptide | Lys-Glu-Asp tripeptide | Longevity & cellular | ≥99% HPLC | 10 mg, 20 mg |
| Agua BAC | bacteriostatic water, BAC water, 0.9% benzyl alcohol water | 0.9% benzyl alcohol, 30 mL | Laboratory supplies | USP grade | 30 mL |